Different Radiological Criteria for Early Tumor Response Evaluation in Patients With Unresectable Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody Plus Bevacizumab

PURPOSE: We aimed to compare different radiological criteria in evaluating the early tumor response of patients with unresectable hepatocellular carcinoma (uHCC) treated with an anti-programmed cell death protein 1 (PD-1) antibody plus bevacizumab. METHOD: From October 2018 to January 2020, 58 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ying, Yang, Yi, Li, Lu, Zhou, Aiping, Zhang, Hongmei, Ye, Feng, Zhang, Wen, Zhao, Hong, Zhao, Xinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063040/
https://www.ncbi.nlm.nih.gov/pubmed/35515116
http://dx.doi.org/10.3389/fonc.2022.848129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063040/
https://www.ncbi.nlm.nih.gov/pubmed/35515116
http://dx.doi.org/10.3389/fonc.2022.848129

Ejemplares similares